Therapies In Thoracic Malignancies An Issue Of Surgical Oncology Clinics Of North America E Book

This issue of Surgical Oncology Clinics of North America, guest edited by Drs. Usman Ahmad and Sudish Murthy, is devoted to Emerging Therapies in Thoracic Malignancies. Drs. Ahmad and Murthy has assembled expert authors to review the following topics: Mediastinal Germ Cell Tumors: Updates in Diagnosis and Management; Multidisciplinary Evaluation and Management of Early Stage Esophageal Cancer; Evaluation of Risk for Thoracic Surgery; Mesothelioma: Updates in Staging and Management; Chest Wall Sarcoma: When and Who to Resect and How to Reconstruct; Management of Locally Advanced Esophageal Cancer; Locally Advanced Lung Cancer and Salvage Resections; Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination; Current Indications for Pulmonary Metastasectomy; Lung Cancer Screening; Thymic Malignancies: Updates in Treatment and Staging; Intra-operative Detection and Assessment of Lung Nodules; Targeted Therapies, Immunotherapy and T-Cell Therapy in Lung Cancer; and more!

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Krasna, is devoted to Lung Cancer. Dr. Krasna has assembled expert authors to review the following topics: Epidemiology for Lung Cancer; Screening for Lung Cancer; Pathology for Lung Cancer; Treatment of Patients with Oligometastatic Disease for NSCLC; SBRT/Ablative Therapies for NSCLC; Mediastinal Staging for Lung Cancer; VATS Lobectomy for NSCLC; Robotic Lung Resection for NSCLC; Pneumonectomy for NSCLC; Bronchoscopy-Diagnostic and Therapeutic for NSCLC; Neoadjuvant Therapy for Lung Cancer; Molecular/Targeted Therapy for Lung Cancer; Adjuvant Therapy for Stage 1and 2 NSCLC, and more!

In this issue of Surgical Oncology Clinics of North America, Guest Editor Mark Krasna and colleagues discuss a wide range of topics devoted to lung cancer. Articles focus on pathology; updated staging systems; epidemiology of lung cancer - smoking, second hand smoke, and genetics; molecular markers for incidence, prognosis, and response to therapy; screening; diagnostic work-up; non-invasive staging techniques; surgical resection; the role of surgery following induction therapy for stage III NSCLC; the role of adjuvant chemotherapy in NSCLC (stages I-III); and much more.

This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!

This issue of Thoracic Surgery Clinics, Guest Edited by Drs. Jean Deslauriers, F.G. Pearson, and Farid Shamji, is devoted to surgery and chemotherapy for lung cancer. This issue was written as a tribute to Dr. Robert J. Ginsberg, and will include articles on: Contemporary results of surgical resection of NSCLC after induction therapy; Prediction of operative morbidity and mortality before operation; Limited resection for small diameter tumors; Management of tumors involving the chest wall, including Pancoast tumors and tumors invading the spine; Role of surgery in patients with clinical N2 disease; Reconstruction of the bronchus and pulmonary artery; Current status of systematic lymph node dissection versus lymph node sampling; Intraoperative nodal staging: Role of sentinel node technology; Stereotactic body radiation therapy (SBRT) in early stage tumors; Palliative resection; Adjuvant chemotherapy after pulmonary resection for lung cancer; Targeted therapy and new anti-cancer drugs in advanced disease; Biologic approaches to drug selection and targeted therapies; Cost effective methods for follow-up after lung cancer surgery; Quality of life after pulmonary resection; and Principles of palliative care.

This issue of Thoracic Surgery Clinics of North America, guest edited by Dr. Michael Lanuti, is devoted to Current Controversies in Thoracic Surgery. Dr. Lanuti has assembled expert authors to review the following topics: Management of Stage IIIA Non-Small Cell Lung Cancer; Management of Oligometastatic Non-Small Cell Lung Cancer; Current Treatment of Mesothelioma (Extrapleural Pneumonectomy or Pleurectomy); Stents as Primary Therapy for Esophageal Perforation; Lymph Node Dissection and Pulmonary Metastectomy; Mediastinal Staging: Endobronchial Ultrasound or Mediastinoscopy; Induction Therapy for Esophageal Cancer; Appropriate Surgical Treatment of Stage I Non-Small Cell Lung Cancer; Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer; Benefit of Plication for Paralyzed Diaphragm; Video-assisted Thoracoscopic Surgery (VATS) Sympathectomy for Hyperhidrosis; Induction Therapy for Thymoma, and more!

This issue of the Surgical Oncology Clinics of North America, Guest Edited by Dr. William G. Cance, is devoted to Translational Cancer Research for Surgeons. Translational Cancer research aims to move bench research to the bedside by applying basic science toward potential therapies. This issue will present the concepts of translational research and development of targeted therapeutics, and its implications for surgeons. It will show clinical applications for surgeons regarding sarcoma/GIST, melanoma, colorectal cancer, breast cancer, and endocrine cancer.

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Elin R. Sigurdson, is devoted to Clinical Trials in Surgical Oncology. Dr. Sigurdson has assembled expert authors to review the following topics: Commentary on Randomized Controlled Trials; Randomized Clinical Trials in Soft Tissue Sarcoma; Randomized Clinical Trials in Gastrointestinal Stromal Tumors; Randomized Clinical Trials in Melanoma; Randomized Clinical Trials in Breast Cancer; Randomized Clinical Trials in Gastroesophageal Carcinoma; Randomized Clinical Trials in Hepatocellular Carcinoma; An Update on Randomized Clinical Trials in Advanced and Metastatic Colorectal Carcinoma; Randomized Clinical Trials in Colon and Rectal Cancer; Randomized Clinical Trials in Anal Cancers; The Elderly in Randomized Clinical Trials; Hereditary Syndromes in Clinical Trials; Future Clinical Trials: Genetically Driven Trials; Randomized Clinical Trials in Neuroendocrine Tumors, and more!